🇺🇸 FDA
Patent

US 8067417

Imidazo[1,2-F]pteridines useful as inhibitors of protein kinases

granted A61PA61P1/16A61P11/06

Quick answer

US patent 8067417 (Imidazo[1,2-F]pteridines useful as inhibitors of protein kinases) held by Vertex Pharmaceuticals Incorporated expires Mon Nov 24 2031 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Vertex Pharmaceuticals Incorporated
Grant date
Tue Nov 29 2011 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 24 2031 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
27
CPC classes
A61P, A61P1/16, A61P11/06, A61P19/08, A61P25/00